PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34589431-0	2021	Four and a Half LIM Domains Protein 2 Mediates Bortezomib-Induced Osteogenic Differentiation of Mesenchymal Stem Cells in Multiple Myeloma Through p53 Signaling and beta-Catenin Nuclear Enrichment.	Bortezomib	47-57	tumor protein p53	Homo sapiens	147-150	
34589431-12	2021	In conclusion, FHL2 is critical for Bzb-induced osteoblast differentiation of MM-MSCs and promotes the osteogenesis, through p53 signaling and beta-catenin activation.	Bortezomib	36-39	tumor protein p53	Homo sapiens	125-128